Navigation Links
America's Pharmaceutical Research Companies Donate $25 Million to Relief Efforts in Haiti; More Help Coming
Date:1/29/2010

WASHINGTON, Jan. 29 /PRNewswire-USNewswire/ -- As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechnology companies continue to provide help.  So far, more than $25 million in medicines, medical supplies and cash have been committed to relief efforts – and that amount is still growing.  The total does not include the contributions of PhRMA member company employees and the many companies committed to matching the pledges of their workers.

PhRMA companies making donations include: Abbott, Amgen Inc., Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., Eisai Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline, Inspire Pharmaceuticals, Inc., Johnson & Johnson, Eli Lilly and Company, Lundbeck Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Otsuka America, Inc., Pfizer Inc, Purdue Pharma L.P., sanofi-aventis U.S., Takeda Pharmaceuticals North America, Inc. and Talecris.

PhRMA President and CEO Billy Tauzin said: "The day the news broke about the tragedy in Haiti, America's biopharmaceutical companies got to work – coordinating efforts with relief organizations and health care groups already on the ground – making sure everything from simple antibiotic creams to critical medicines were made accessible to victims. And the more the need for medicinal aid is defined, the more our companies are providing it."

Some of the medical and disaster relief organizations that PhRMA companies are coordinating with in Haiti include the World Health Organization, UNICEF and the Red Cross (via various national associations), as well as Americares, Catholic Medical Mission Board, Direct Relief International, MAP International, Partners in Health, Project HOPE, Save the Children and World Vision.

PhRMA is also involved in the Haitian effort through the Rx Response program.  This program, which was developed following Hurricane Katrina, has shed light on the most effective methods to donate medical products and the most efficient ways medical professionals can volunteer for the Haiti response effort.

"The vital role of PhRMA companies and their employees in the global community is clearly defined by such catastrophic situations.  It's our civic responsibility to provide health care professionals the tools they need to help save lives, and we're proud to take part in this effort, which will lead to the eventual recovery of Haiti," Tauzin said.

The Pharmaceutical Research and Manufacturers of America  (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For more information on public health emergencies, visit http://www.rxresponse.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info

SOURCE Pharmaceutical Research and Manufacturers of America

RELATED LINKS
http://www.phrma.org/

'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Accuray Announces Regionalized Management Strategy for Americas
2. Pres. Clinton Announces Commitment From Inter-American Development Bank, Global Network for Neglected Tropical Diseases, and Pan American Health Organization to Mobilize $30 Million to Fight NTDs in the Americas at CGI Conference
3. Diffusion Pharmaceuticals LLC Closes on $5.9 Million Financing
4. New Research from Best Practices Can Save Biopharma Companies Millions: Pharmaceutical New Product Planning - Structure and Activities to Drive Profitability
5. Ophthalmic Pharmaceutical Drugs - A Global Market Perspective
6. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
7. Intercept Pharmaceuticals Raises $25 Million Series B Financing
8. Poniard Pharmaceuticals Announces Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives
9. Amylin Pharmaceuticals to Webcast Year-End Financial Results
10. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
11. New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... PORTLAND, Oregon and PUNE, India ... According to a new report published by Allied Market ... Global Opportunity Analysis and Industry Forecast, 2014-2022," the ... million by 2022, from $5,768 million in 2015, growing ... The chemical & gas sterilization segment dominated the market ...
(Date:1/16/2017)... Bill is an internationally experienced medical device industry executive ... with global medical device companies, including Smith & Nephew, Angiodynamics, Orthovita ... products and building successful businesses in the sector and has worked ... and North America . ... Educated at the University of Edinburgh (Dental ...
(Date:1/16/2017)... 2017 CBDRx, the world,s premiere nutraceutical hemp ... rich hemp extract to Veteran,s groups across the country. ... hemp extract to Veteran,s groups across the United States.  ... in the world and through their passion, CBDRx honors ... phyto-nutrient rich hemp extract available. ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... ... San Francisco dentist, Dr. Ben Amini , the founder at CitiDent, ... capable of taking digital impressions of teeth and gums. Conventional bite impressions have lagged ... , in terms of speed, efficiency and patient comfort. Increasingly, digital impressions are being ...
(Date:1/16/2017)... ... ... NexTec Group has been selected as a member of the Bob Scott’s ... the field of midmarket financial software. , Members of the VAR Stars were selected ... based on revenue and those firms chosen represent a wide range of size and ...
(Date:1/15/2017)... , ... January 15, 2017 , ... ... Community Outreach is a program that strives to better communities around the world ... locations’ community. It also provides the opportunity for team members to become involved ...
(Date:1/15/2017)... ... January 15, 2017 , ... Accreditation ... achieved accreditation for its specialty care services. Albertsons Companies is the largest ... care service for pharmacy patients. , Accreditation by ACHC reflects Albertsons Companies’ dedication ...
(Date:1/15/2017)... ... January 15, 2017 , ... San Francisco ... eight Bay Area counties for 2017. Almost 1,000 nominations were submitted and a ... award process. Results were announced the magazine’s January 2017 issue . , ...
Breaking Medicine News(10 mins):